Improve your health

The possibility of remote monitoring for chronically ill patients will soon become a reality. Now, researchers in South Africa and Australia have devised a decentralized system to avoid medical data overload. They describe the peer-to-peer system in a forthcoming issue of the International Journal of Computer Applications in Technology.
People with a range Continue Reading »

The European Commission has granted marketing authorisation for Servier’s
Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant
for the treatment of adult patients with major depressive episodes.
devastating effects of depression," said Professor Goodwin from Warneford
Hospital, Oxford, United Kingdom. "Valdoxan is Continue Reading »